Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 agonist and oxygen strategy trial in cardiac surgery
2015-003050-41Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of exenatide in Chronic Coronary Syndrome (CCS) (4 arms), sponsored by Rigshospitalet. Started Jul 2015; status: completed.
02
Drugs
exenatide
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on 2015-003050-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003050-41.